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ABSTRACT
Objectives Aboriginal and Torres Strait Islander
Australians have a substantially greater fracture risk,
where men are 50% and women are 26% more likely to
experience a hip fracture compared with non-Indigenous
Australians. Fall-related injuries in this population have
also increased by 10%/year compared with 4.3%/year in
non-Indigenous Australians. This study aims to determine
why falls and fracture risk are higher in Aboriginal and
Torres Strait Islander Australians.
Setting All clinical assessments will be performed at one
centre in Melbourne, Australia. At baseline, participants
will have clinical assessments, including questionnaires,
anthropometry, bone structure, body composition and
physical performance tests. These assessments will be
repeated at follow-up 1 and follow-up 2, with an interval of
12 months between each clinical visit.
Participants This codesigned prospective observational
study aims to recruit a total of 298 adults who identify
as Aboriginal and Torres Strait Islander and reside within
Victoria, Australia. Stratified sampling by age and sex
will be used to ensure equitable distribution of men and
women across four age-bands (35–44, 45–54, 55–64 and
65+ years).
Primary and secondary outcome measures The
primary outcome is within-individual yearly change
in areal bone mineral density at the total hip, femoral
neck and lumbar spine assessed by dual energy X-ray
absorptiometry. Within-individual change in cortical
and trabecular volumetric bone mineral density at
the radius and tibia using high-resolution peripheral
quantitative computed tomography will be determined.
Secondary outcomes include yearly differences in physical
performance and body composition.
Ethical approval Ethics approval for this study has been
granted by the Monash Health Human Research Ethics
Committee (project number: RES-19–0000374A).
Trial registration number ACTRN12620000161921.

INTRODUCTION
Background and rationale
Aboriginal and Torres Strait Islander Australians have a substantially greater fracture
risk than non-
Indigenous Australians. For

Strengths and limitations of this study
► This study has been codesigned using a bottom-up

►

►

►

►

approach with Aboriginal and Torres Strait Islander
community members.
Comprehensive bone and muscle assessments will
be performed using the latest cutting-edge imaging
technology.
Data on modifiable lifestyle factors, such as diet,
physical activity and quality of life, will be collected
through questionnaires.
Clinical indicators of key risk factors for falls and
fractures will be assessed via medical history, blood
biochemistry and novel imaging assessments (abdominal aortic calcification).
The study population will be recruited from one
Australian state (Victoria) suggesting limited generalisability to Aboriginal and Torres Strait Islander
Australians across the entire country as there may
be differences between various regions.

minimal trauma fractures, defined as fractures that result from trauma equal to or less
than a fall from standing height, Aboriginal
and Torres Strait Islander men and women
are 50% and 26%, respectively, more likely to
experience such fractures compared with non-
Indigenous Australians.1 Hip fractures also
occur at a much younger age in Aboriginal
and Torres Strait Islander people compared
with non-
Indigenous Australians, for men,
this is 65 versus 81 years, while for women,
this is 74 versus 83 years, respectively.1 Additionally, over a 10-year period (1999–2009),
there was a disproportionate increase in age-
related hip fracture rates by 7.2% per year for
Aboriginal and Torres Strait Islander Australians, while rates declined by 3.4% per year
in non-Indigenous Australians.2 The occurrence of minimal trauma fractures in older
people has been associated with an increased
risk of subsequent fracture and premature
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mortality.3 4 Prevalence of chronic disease, such as cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM)
and chronic kidney disease (CKD), is also higher in
Aboriginal and Torres Strait Islander Australians; these
comorbidities are associated with increased risks of osteoporosis, falls and fracture.5 However, currently, there
are no data or studies that explain the mechanisms for
increased fall and fracture risk in Aboriginal and Torres
Strait Islander Australians.
One of the primary causes of fracture is falls, with
several studies reporting a greater number of falls among
Aboriginal and Torres Strait Islander people compared
with non-
Indigenous Australians. The number of fall-
related injuries increased by an average of 10% per
year in Aboriginal and Torres Strait Islander Australians
compared with 4.3% per year in non-Indigenous Australians during years 2007–2011.6 In a 9-year follow-up study
(2003–2011), the rates of hospitalisation for fall-related
fractures were increased by 3.0% annually for Aboriginal
and Torres Strait Islander people compared with 0.7%
annually for non-Indigenous Australians.7
To date, only two studies have reported areal bone
mineral density (aBMD) among Aboriginal and Torres
Strait Islander Australians—both in relatively small
samples. The first study measured whole-body aBMD in
16 Aboriginal and 16 non-Indigenous women in Sydney,
Australia and reported no significant differences between
the two groups.8 The second study9 measured hip and
spine aBMD in a group of 166 Aboriginal and Torres Strait
Islander Australians aged >17 years (58% women) living
in very remote and regional (outer) locations.10 It showed
greater femoral neck aBMD in Aboriginal and Torres
Strait Islander adults compared with non-
Indigenous
adults (n=36).9 No differences were reported in lumbar
spine aBMD, even after adjusting for body composition.9
Despite higher aBMD being reported for Aboriginal and
Torres Strait Islander Australians in this study, their fracture prevalence is higher compared with non-Indigenous
Australians. The findings from that study were limited as
the participants were not representative of the Aboriginal and Torres Strait Islander population (12% live
in very remote and 19% live in outer regional areas11)
and data were from two studies that were not empirically designed to examine aBMD, but instead to assess
CKD, metabolic and inflammatory associations with body
composition. Small group numbers and recruitment of
participants from two diverse regions (Darwin, Northern
Territory and Thursday Island, Queensland) may have
further increased the variance in the study sample. In
addition, body composition (fat and lean mass) of the
non-Indigenous group was not provided, which may have
influenced the data, as fat and lean mass have differing
effects on aBMD.
Dual-energy X-ray absorptiometry (DXA) is the current
clinical gold-standard tool used to predict fracture risk
and measures aBMD (g/cm2). A T-score (SD from young
adult mean aBMD)≤−2.5 SD is defined as osteoporosis
by the WHO. Although DXA has many advantages, with
2

good precision, very low radiation and providing measurements at sites prone to osteoporotic fracture, DXA cannot
fully account for bone size12 or measure trabecular and
cortical bone density—known contributors to bone
strength and fracture risk. These components of bone
strength may be compromised in Aboriginal and Torres
Strait Islander Australians, contributing to their higher
fracture rates.12 In particular, the separate bone compartments (cortical vs trabecular), bone geometry (shape
and size), microarchitecture (organisation of trabecular
bone) and bone strength (buckling vs strain). However,
with advancements in bone imaging technology, these
components of bone strength can now be measured using
high-resolution peripheral quantitative computed tomography (HR-pQCT). Evidence shows that bone microarchitecture and estimates of bone strength from HR-pQCT
using microfinite element analysis (µFEA) are more accurate at determining minimal-trauma fracture risk than
DXA-derived aBMD.13
It should be noted, the utility of DXA scans go beyond
musculoskeletal outcomes. Specifically, DXA scans of
the lateral spine can also be used to assess abdominal
aortic calcification (AAC), a marker of advanced vascular
disease, also linked to measures of atherosclerosis at
other vascular beds,14 greater cardiovascular disease
risk,15 poorer muscle strength,16 greater injurious fall17
and fracture risk.15 Collectively, these studies demonstrate
a critical nexus between the vascular and musculoskeletal
systems, which warrant investigation in Aboriginal and
Torres Strait Islander Australians.
During 2008–2012, CVD was the leading cause of death
among Aboriginal and Torres Strait Islander Australians,
with an age-standardised death rate of 1.5 times that of
non-Indigenous Australians.18 CVD, particularly atherosclerosis, and osteoporosis are common in the ageing
population. There is an overlap in the risk factors for CVD
and osteoporosis, which may partly explain the higher
prevalence of CVD and fractures among Aboriginal
and Torres Strait Islander Australians.19 Recently, associations between AAC, lower aBMD,20 greater bone loss
over time21 and fragility fractures22 have been reported.
Peripheral artery disease is associated with peripheral
vascular calcification (PVC) in the legs, with a greater
prevalence reported in people with diabetes.23 A novel
quantitative method using HR-pQCT can now not only
assess the presence of PVC but also the severity, as the
density of the calcified vessels can now be measured.24
The prevalence of T2DM is three times greater among
Aboriginal and Torres Strait Islander people compared
with non-
Indigenous Australians,18 25 with diabetes-
related mortality almost seven-fold greater in the Aboriginal and Torres Strait Islander population.26 Those with
T2DM are more prone to falls due to reduced balance
caused by complications such as peripheral neuropathy,
retinopathy and reduced muscle strength, all of which are
well-recognised risk factors for falls.27 Despite generally
demonstrating higher aBMD, fracture risk is increased
in those with T2DM due to decreased bone strength,28 29
Zengin A, et al. BMJ Open 2022;12:e056589. doi:10.1136/bmjopen-2021-056589
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specifically increased cortical porosity and cortical pore
volume.23 30 Shared factors may result in a higher risk
of both T2DM and osteoporosis among Aboriginal and
Torres Strait Islander Australians, independent of each
other.
The prevalence of CKD is high among Aboriginal
and Torres Strait Islander Australians31 as national data
reported one in five Aboriginal and Torres Strait Islander
people had indicators of CKD and an estimated glomerular filtration rate (eGFR) <90 mL/min/1.73 m² with
albuminuria.32 End-stage kidney disease is reported to
be 10–15 times higher in Aboriginal and Torres Strait
Islander Australians compared with non-
Indigenous
Australians.33 34 There are also other contributing risk
factors with CKD in Aboriginal and Torres Strait Islander
Australians, such as social disadvantage, remoteness
and lifestyle differences.31 Renal osteodystrophy in CKD
is multifaceted and encompasses increased fibroblast
growth factor 23,35 secondary hyperparathyroidism36
and abnormal calcium-phosphate metabolism.37 Muscle
wasting and sarcopenia is highly prevalent in those with
CKD,38 increasing frailty and falls risk39 and consequently
increasing fracture risk.
There is sparse data on musculoskeletal health knowledge and/or attitudes of Aboriginal and Torres Strait
Islander people. Chronic pain is frequently associated with
chronic diseases, such as osteoporosis and other musculoskeletal disorders. A qualitative study on the perceptions
of pain among Aboriginal people from a rural region in
southeast Queensland revealed that Aboriginal people
were reluctant to report their pain due to negative experiences within the healthcare system.40 This study also
reported that participants had expressed difficulties in
communicating their pain with healthcare professionals,
and, in turn, understanding what they were being told
due to use of jargon by healthcare professionals.40 An
educational programme that is culturally appropriate
and codesigned with community will not only increase
musculoskeletal health knowledge among Aboriginal and
Torres Strait Islander Australians but also empower them
to communicate their pain.

12-month intervals between each study visit. This study
will be conducted at the Monash Medical Centre, School
of Clinical Sciences, Translational Research Facility
Precinct of Monash University, Melbourne Australia. In
total, we will recruit 298 Aboriginal and Torres Strait
Islander Australians residing in Victoria and will stratify
our recruitment by age-band (35–44, 45–54, 55–64, 65+
years) and sex.

Objectives
The primary aim of this study is to provide the first-ever
data regarding the prevalence of osteoporosis across the
ageing spectrum in Aboriginal and Torres Strait Islander
Australians over a 2-year period. This will be done by
assessing within-individual yearly change in skeletal and
muscular characteristics known to exacerbate falls and
fracture risk. Secondary aims are to (1) identify lifestyle
(dietary intake, physical activity) and comorbidity (CVD,
T2DM, CKD) determinants of bone and muscle strength
loss during ageing and (2) improve health literacy in
musculoskeletal health with a community-based educational programme.

METHODS
Patient and public involvement statement
This study arose from hospital data, which highlighted
the missing gaps in musculoskeletal health and discussions with community across diverse settings and has been
developed through extensive consultation. The Study of
Indigenous Muscle and Bone Ageing (SIMBA) has been
codesigned using a bottom-up approach with Aboriginal
and Torres Strait Islander community members to ensure
that the study is culturally sensitive and appropriate.
Over the past 4 years, study investigators have established a long-standing and strong relationship with the
Bunurong Health Service nestled within the Dandenong
& District Aborigines Cooperative Limited (DDACL),
who are in full support of SIMBA. Elders were consulted
and all suggestions have been incorporated into the study
design. In particular, discussions with Elders (who are
respected leaders within the community) and community
members explained their own personal mobility disabilities, fractures and musculoskeletal pain. As they have
had personal experience with these, they expressed how
important a study like this is for their people, as they articulated similar situations among family and friends (online
supplemental text 1). All clinical assessment procedures
and each question in the questionnaires have been individually checked and modified by Aboriginal investigators (JO and TW) to ensure appropriate use of language
and suitability. JO is not only the CEO of the DDACL and
has over 20 years’ experience in the Aboriginal health
service but is also a Wurundjeri Woi-Wurrung Elder in the
Aboriginal community. TW is a Yorta Yorta man who has
expertise in the skeleton and human movement as he is
a practising chiropractor and strength and conditioning
coach as well as a scientist in the musculoskeletal field.
The introductions and semistructured questions for the
focus group sessions have been developed and modified
with Aboriginal community members and then checked
and approved by Aboriginal investigators (JO and TW).
Study governance mechanisms will ensure that engagement is ongoing throughout the implementation of the
study, and during data analysis and interpretation. Benefits to community have been discussed and identified by
Aboriginal and Torres Strait Islander people during the
consultation process (online supplemental text 2).

Study design
This will be a prospective observational study with three
time points (baseline, follow-up 1 and follow-up 2) with

Study setting
This study will be conducted in community-
dwelling
Aboriginal and Torres Strait Islander men and women,
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aged +35 years, recruited from the general population
in Victoria. Participants will be recruited using various
methods, including: advertising posters displayed at
various locations, screening the patient database at the
Bunurong Health Service, referrals from clinicians at
Monash Health; engagement with Aboriginal communities, Yarning circles and Gathering places and word of
mouth originating from any of the above methods. Potential participants will then contact study staff to undergo
eligibility screening.
Eligibility criteria
A screening questionnaire over the telephone will be
performed by research study staff, and eligibility will be
assessed based on the inclusion/exclusion criteria. Participants who are eligible and willing to proceed will be
scheduled for a study visit; after screening participants
will be mailed or emailed a copy of the Participant Information Consent Form (PICF) with all the study details.
Written informed consent will be taken at the time of the
study visit.
Inclusion and exclusion criteria
Participants included will be Aboriginal and Torres Strait
Islander adults, defined as an individual who identifies as
being Aboriginal and/or Torres Strait Islander; aged 35
years or older; body weight less than 160 kg (maximum
rating of imaging machines); not pregnant, not lactating
and not breast feeding in the last 6 months (applicable to
women only); at least one side of the body must be free
from any metal or other material in limbs or surrounding
locations that could interfere with imaging; fluent in
written and spoken English, has capacity to provide
informed consent and can communicate effectively with
researchers; and no other medical condition that in the
opinion of the investigators may deem inclusion unsafe or
inappropriate, for example, recent exposure to nuclear
medicine; pregnancy; conditions that may reduce ability
to remain supine during bone imaging (eg, vertigo);
conditions that may reduce ability to remain still during
scans (eg, Parkinson’s disease, motor-neuron disease).

ASSESSMENTS
The study flowchart is summarised in figure 1. At baseline, all participants will attend their study appointment
and all the assessments detailed in figure 1 and table 1
will be performed. Participants will then be scheduled for
a follow-up visit 12 months later to repeat all assessments
except the health awareness questionnaire and blood
tests. Six months following the follow-up 1 study visit, all
participants will be invited (but not required) to attend
the community-
based educational programme. Participants will be scheduled for the follow-up 2 visit 12 months
after follow-up 1. The first study participant attended the
baseline visit on 17 December 2020; the anticipated date
for the final follow-up 2 visit is December 2024 (due to
disruptions caused by COVID-19 lockdowns).
4

Community-based educational programme
After attending the follow-
up 1 appointment, study
participants will be invited to attend the community-
based educational programme on bone and muscle
health. Musculoskeletal health literacy will be measured
by a questionnaire at baseline and after the educational
programme, to measure any improvement in musculoskeletal health literacy.
To help determine the most effective and beneficial
community educational programme, four focus groups
(or until data saturation) will be conducted with an aim to
develop the educational curriculum. Data from the focus
groups will be synthesised, which will allow for codesign of
the educational programme to pilot it in this study, using
a bottom-up approach to ensure that the programme is
effective in delivering the content in a culturally sensitive
way that is appropriate for the Aboriginal and Torres Strait
Islander community. The focus groups, each comprising
of approximately 5–6 Aboriginal and Torres Strait Islander
community members representing each of the four age-
bands in the study sample, will be conducted in a round
table open discussion format. The focus groups will be
a shared discussion with cultural moving parts and will
be overseen and sat-in with Aboriginal study investigators
(JO and TW) and other Aboriginal and/or Torres Strait
Islander community champions. Storytelling is a feature
of Aboriginal culture, a method of information sharing,
where this style of informal and relaxed dialogue is called
yarning.41 With the consent of the focus group attendees,
the sessions will be recorded to allow review following the
session, and to ensure no information is overlooked when
finalising the content and delivery method of the educational programme.
The focus group sessions will aim to identify knowledge
gaps that currently exist among Aboriginal and Torres
Strait Islander people; what they think they should learn;
the existing barriers to osteoporosis screening; an effective format for the educational seminars (eg, PowerPoint
presentations, separate groups for men and women, small
group sizes); whether question prompt lists regarding
osteoporosis and sarcopenia written specifically for
Aboriginal and Torres Strait Islander Australians would
be beneficial, and if so, what questions would be most
suitable and what the best location would be for the seminars (with regards to access). On evaluation of the needs-
analysis, every aspect, including content and the delivery
format of the educational programme, will be codesigned
(see online supplemental text 3). An example of the
topics that could be covered is listed in table 2, which will
be used as a guide during the focus group sessions. Codesigning the educational programme with Aboriginal and
Torres Strait Islander community members will provide
important insight into how best to design the programme
that will most effectively fill their knowledge gap in
musculoskeletal health. So, if during the focus group
sessions, participants suggest other topics that they deem
more relevant than those considered by researchers, then
the programme will be developed accordingly.
Zengin A, et al. BMJ Open 2022;12:e056589. doi:10.1136/bmjopen-2021-056589
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Figure 1 Study flowchart. aBMD, areal bone mineral density; BMC, bone mineral content; DXA, dual energy x-ray
absorptiometry; HRpQCT, high resolution peripheral quantitative CT; LVA, lateral vertebral assessment; SarQoL, sarcopenia and
quality of life; SPPB, short physical performance battery; vBMD, volumetric bone mineral density.

Use of culturally appropriate and sensitive language
during the programme will be a key focus for researchers,
since it will be of utmost importance in realising the best
possible educational outcomes in combination with the
curriculum design. Once developed, the educational
programme will be scheduled to commence within
1 month of follow-up 1 measurements being concluded.
Process evaluation and implementation will be conducted
throughout the duration of the programme (eg, quarterly if focus groups reveal once per month frequency
over 1 year). This will allow research staff to monitor the
progress of how well the content and delivery is being
received and will subsequently provide early indications as
to whether certain aspects require modification to better
Zengin A, et al. BMJ Open 2022;12:e056589. doi:10.1136/bmjopen-2021-056589

suit the needs of the community members. The quality
appraisal tool from the Centre of Research Excellence
in Aboriginal Chronic Disease Knowledge Translation
and Exchange (CREATE)42 will be used as a framework
to report key elements of the focus groups through an
Aboriginal and Torres Strait Islander cultural lens.
Measurements
Participants will attend the Bone and Muscle Research
Group’s imaging facility located within the Monash
Health Translation Precinct at Monash Medical Centre in
Melbourne, Australia. The total duration of each appointment will be approximately 2–3 hours.
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Table 1 Bone imaging assessments

Table 2

Imaging modality
and site

Theme

Topics to cover

Bone
Muscle

Fractures and treatment
Weak muscles and falls

DXA (Hologic)
 Whole-body

 Total hip

Measurements
 
aBMD; whole body lean and fat mass;
compartmental fat mass (android
and gynoid), appendicular lean mass
(arms+legs lean mass)
aBMD at the total hip and femoral
neck; hip structural analysis

 Lumbar spine scan aBMD; TBS
 (anterio-posterior,
L1-L4)
 Lateral vertebral
assessment

Abdominal aortic calcification score;
vertebral fracture

pQCT (Stratec)

 

 4% radius

Total vBMD, trabecular vBMD

 33% radius

Total vBMD, cortical vBMD,
cortical area, stress strain index,
cross-sectional moment of inertia,
endocortical and periosteal
circumference

 66% radius

Cross-sectional muscle area, muscle
density

 4% tibia
 38% tibia

 66% tibia

Total vBMD, trabecular vBMD,
presence of PVC
Total vBMD, cortical vBMD,
cortical area, stress strain index,
cross-sectional moment of inertia,
endocortical and periosteal
circumference, presence of PVC
Cross-sectional muscle area, muscle
density, presence of PVC

HR-pQCT (Xtreme-CTII, Scanco)
 4% radius

Total vBMD, trabecular vBMD

 30% radius

Total vBMD, cortical vBMD,
cortical area, stress strain index,
cross-sectional moment of inertia,
endocortical and periosteal
circumference

 4% tibia

Total vBMD, trabecular vBMD,
presence of PVC
Total vBMD, cortical vBMD,
cortical area, stress strain index,
cross-sectional moment of inertia,
endocortical and periosteal
circumference, presence of PVC

 30% tibia

aBMD, areal bone mineral density; DXA, dual-energy x-ray
absorptiometry; HRpQCT, high-resolution CT; pQCT, peripheral
quantitative CT; PVC, peripheral vascular calcification; TBS,
trabecular bone score; vBMD, volumetric bone mineral density.

Anthropometry
Participants’ weight (kg) will be measured to the nearest
0.1 kg, using electronic scales (Seca 804, Seca, Germany).
Participants’ height (cm) will be measured to the nearest
6

Potential topics for educational programme

Chronic diseases Heart disease, kidney disease and
diabetes
Exercise

Healthy living
across the
lifecourse

Different modalities of exercise for
example, running, walking, lifting weights
(load bearing exercises)
Across the different phases of life:
childhood, adulthood and ageing

0.1 cm, using a wall-mounted stadiometer (Seca 213, Seca,
Germany).
Blood pressure
Blood pressure measurements will be taken three times
each for systolic and diastolic blood pressure and pulse
rate after using an automated device (Omron HEM-907,
Omron Australia, Australia) after the participant has
been supine for 10 min. The ankle-brachial index will
then be measured, which is a non-invasive measure for
peripheral artery disease, calculated from the systolic
blood pressure from the ipsilateral arm and ankle. It is
calculated as ankle systolic blood pressure divided by arm
systolic blood pressure.43 44
Blood biochemistry
Fasting blood samples will be collected to measure clinical indicators of key risk factors for falls and fractures.
These include T2DM (glycated haemoglobin, HbA1c;
fasting blood glucose), CKD (urea, electrolytes, creatinine, eGFR), CVD (high-density lipoproteins, low-density
lipoproteins, very low-density lipoproteins, triglycerides,
total cholesterol) and chronic liver disease. Vitamin
D will also be measured using the gold-standard liquid
chromatography–mass spectrometry method. Additional
aliquots of samples will be collected and stored for testing
of further analytes when funding becomes available (eg,
bone turnover markers, cytostatin C). Non-fasting blood
samples will be collected when fasting is not feasible.
Questionnaires
Participants will complete the questionnaires at various
times during their study visit, to ensure that they are
not overburdened with completing the questionnaires
all in the one sitting. The following questionnaires are
designed to assess demographic, medical and lifestyle
factors that are known to influence musculoskeletal
health. Data collected will include the following: general
demographics (including history on fractures and falls);
reproductive history (women only); medical history;
sarcopenia and quality of life45 46; Cancer Council of
Victoria food frequency questionnaire; short form of
Zengin A, et al. BMJ Open 2022;12:e056589. doi:10.1136/bmjopen-2021-056589
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the international physical activity questionnaire47; osteoporosis knowledge assessment tool48 and osteoporosis
health belief scale.49
Dual-energy X-ray absorptiometry
Participants will undergo one DXA scan (Hologic
Discovery A, Hologic, USA) at each of the four anatomical sites specified in table 1. Total bone density (mg/
cm3) and bone area (mm2) will be measured at each
anatomical site using manufacturer’s thresholds, to determine aBMD and bone mineral content. Body composition will be measured for whole body (lean and fat mass),
android and gynoid fat mass, and appendicular lean mass
(arms plus legs lean mass). The lumbar spine scan will
also be used to estimate the trabecular bone score, where
a higher value correlates with better skeletal microstructure.50 51 The lateral vertebral assessment will be used
to ascertain vertebral fractures and quantify AAC14 52 to
assess risk factors for CVD. AAC will be scored using a
semiquantitative scoring system (scored 0 to 24; AAC24).
This involves assessing the linear length of the vascular
calcification in the aorta relative to the L1–L4 lumbar
vertebra.52–56
Peripheral quantitative computed tomography
Participants will undergo one pQCT scan (Stratec XCT
3000, Stratec, Germany) at each of the six anatomical
sites specified in table 1. Total, trabecular and cortical
bone density (mg/cm3) and area (mm2), volumetric
bone mineral density (vBMD) and muscle and adipose
indices will be measured using manufacturer’s thresholds.
pQCT scans of the radius and tibia will be performed in
the participant’s non-
dominant limb. Single 2.5 mm
transverse scans will be obtained at 4%, 33%/38% and
66% of limb length measured proximally from the end
plate of the tibia or radius, with a voxel size of 0.8 mm
and scan speed of 20 mm/s. Scans from pQCT will allow
for comparison with other populations, as this imaging
modality is widely used, globally.
High-resolution peripheral quantitative computed tomography
Participants will undergo one HR-pQCT scan (XtremeCT
II, Scanco Medical, Switzerland) at each of the four
anatomical sites specified in table 1. Total, trabecular
and cortical bone density (mg/cm3) and area (mm2),
vBMD, microarchitecture and µFEA will be measured at
each anatomical site using manufacturer’s thresholds.
HR-pQCT scans of the tibia will be performed in the
participant’s non-dominant lower leg positioned inside
the pQCT gantry while seated. Single 10.2 mm transverse
scans will be obtained at 4% and 30% of the radius and
tibia will be measured proximally from the end plate, with
voxel size 0.8 mm and scan speed 20 mm/sec.
Short physical performance battery
The short physical performance battery (SPPB) is the
most highly validated measure of physical performance
and disability in older adults and is widely used in clinical and research settings.57 A summary score of 0 to
Zengin A, et al. BMJ Open 2022;12:e056589. doi:10.1136/bmjopen-2021-056589

12 (higher score indicates better function) is obtained
based on performance in three tasks1: five repeated chair
stands,2 standing balance over 10 s (semitandem and full
tandem) and3 gait speed over a distance of 4 m. A score
of 0–4 is given based on the individual’s performance in
each of the three tests.
Hand grip strength
Hand dynamometry (Jamar Plus Digital Hand Dynamometer; Nottinghamshire, UK) will be used to test the
grip strength of the dominant hand. The participant will
sit in the chair with feet flat on the floor and forearms
supported by the chair arms. The hand should be positioned neutral with the thumb facing upward. The dynamometer will be adjusted to fit the participant’s hand
comfortably when at rest with the tips of the third and
fourth fingers aligned between the forward and rear grips.
The participant will be instructed to squeeze the handle
and breathe out gently. This will be repeated three times
in total, with the maximum hand grip strength (HGS; kg)
taken as the measurement for analyses.
Jumping mechanography
A Leonardo Mechanograph Ground Reaction Force
Platform LT (Novotech Medical GmBH, Germany) will
measure peak forces and power in the lower limb. It
involves real-time recording of force, velocity and power
in the leg from a ‘usual’ daily task and is considered a
useful addition to other traditional tests. It has been validated as a reproducible tool that enables anatomical site-
specific assessment corresponding to loading, falls and
fracture in older adults.58 59 Tests include (1) a single two
leg jump to measure peak muscle power (kW), where the
participant will be instructed to jump as high as possible
using both legs, bending the knees and using the arms to
help create the power and (2) multiple one leg hopping
test to measure peak muscle force (kN), where the
participant will be instructed to jump, approximately 10
times, as hard and as fast possible on the ball of the foot
without the heel touching the platform. Both tests will be
repeated three times each in total, where the software will
automatically detect which measurement will be taken for
analyses.
Outcome measures
Primary outcome measure
The primary outcome for this study will be within-
individual yearly change in aBMD at the total hip, femoral
neck and lumbar spine assessed by DXA. In addition to
within-individual yearly change in cortical and trabecular
bone volumetric mineral density at the metaphysis and
diaphysis of the radius and tibia using HR-pQCT.
Secondary outcomes
Secondary outcomes will assess yearly changes in: body
composition (fat mass and lean mass compartments),
physical function (SPPB), muscle strength (force, power
and HGS), blood biochemistry including clinical risk
factors for chronic diseases (T2DM, CVD and CKD),
7
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lifestyle characteristics (dietary intake, physical activity
and quality of life) and blood pressure.
Sample size
The required sample size for this study is 298 participants
(n=148 men and n=148 women). A power calculation
based on 298 participants has been performed to produce
a two-sided 95% CI with a width of 0.04, a 20% precision
(based on the DXA site with the worst precision, that is,
femoral neck), to detect a within-individual change of 2%
per year (ie, a rate that has been documented in other
populations) and a 20% loss-to-follow-up. In the other
DXA skeletal sites and HR-pQCT regions, which can be
measured with more precision, smaller rates of change
will be detectable with this number of participants. The
rates of bone loss will differ between men and women
and may alter with age; the greatest bone loss in non-
Indigenous Australians occurs in women in the first 5–10
years after menopause. Therefore, the sample size has
been determined to allow investigation of bone loss in
men and women separately. The time interval of 1 year
between scans has been selected to assess bone loss within
an individual over 2 years, as the magnitude of bone loss in
Aboriginal and Torres Strait Islander adults is unknown;
this will ensure the age of osteoporosis (bone fragility)
and sarcopenia (decreased muscle function) onset is not
missed.
Data collection, management and analysis
Study data will be collected using a tablet device and
managed using Research Electronic Data Capture
(REDCap) electronic data capture tools hosted at Monash
University.60 61 REDCap is a secure, web-based software
platform designed to support data capture for research
studies, providing (1) an intuitive interface for validated
data capture; (2) audit trails for tracking data manipulation and export procedures; (3) automated export
procedures for seamless data downloads to common
statistical packages and (4) procedures for data integration and interoperability with external sources. Online
questionnaires have been designed with mandatory
answers required to avoid missing data. Data from blood
analyses will be entered into a Microsoft Access password-
protected database.
Statistical methods
Analysis will be performed using Stata V.15.1 (StataCorp,
USA).62 Descriptive statistics will be used to describe
the participant characteristics at baseline. Data will be
assessed for outliers and normality prior to analysis and
log-transformed if necessary. Baseline and follow-up data
for outcome measures and between-sex differences across
the age-bands will be presented as means and SDs. Linear-
mixed models will compare changes in bone and muscle
parameters, comparing men and women. Multivariable
regression analyses will be performed to determine
whether these associations are independent of potential
8

confounders including age, body composition, comorbidities, physical activity and social demographics.
Additionally, data from SIMBA will be compared with
matched non-
Indigenous Australians to elucidate
age-
differences in bone and muscle health. Together with
Aboriginal investigators, we will work with community
representatives to take a strength-based approach in the
interpretation and presentation of data. This will be done
via an Aboriginal Advisory Group with members formed
through JO’s role as CEO of the Bunurong Health Service,
TW’s position and strong ties within the community and
other community champions. For all analyses, a p value
of <0.05 or 95% CI not including the null point will be
considered statistically significant. The focus groups will
be analysed using a thematic analysis approach, once they
have been transcribed. The data will be uploaded and
analysed using NVivo Qualitative Data Analysis Software
V.20.3 (QSR International).
ETHICS
In accordance with the Australian National Statement on
Ethical Conduct in Human Research,63 64 ethics approval
for this study has been granted by the Monash Health
Human Research Ethics Committee (project number:
RES-
19–0000374A), registered and certified by the
National Health and Medical Research Council (NHMRC)
of Australia. We have adhered to the NHMRC Guidelines
Framework, which includes the AIATSIS Code of Ethics
for Aboriginal and Torres Strait Islander Research65
and the Ethical conduct in research with Aboriginal
and Torres Strait Islander Peoples and Communities:
Guidelines for researchers and stakeholders66; we have
provided specific details on how SIMBA adhered to all
these guidelines (see online supplemental text 4). Briefly,
recruitment, study visits and dissemination strategies used
in SIMBA are based on best practice for cohort studies of
Aboriginal and Torres Strait Islander people.67–69
DISSEMINATION
Results will be communicated to study participants and
communities in lay language, relevant stakeholders and
disseminated in peer-
reviewed academic journals and
presented in scientific meetings and conferences. In addition to interpretation and presentation of findings, the
Aboriginal Advisory Group (mentioned above) will also
provide ongoing advice to study investigators, advising on
how best to communicate and disseminate findings from
SIMBA. Participants can nominate for DXA reports to
be sent to their own doctor, and appropriate social and
Aboriginal and Torres Strait Islander media and forums
will be used to inform participants of study progress and
key outcomes. In particular, findings will be presented at
Aboriginal community centres and shared with the Victorian Aboriginal Community Controlled Health Organisation—as the peak body for health and well-being of
Aboriginal people living across the state of Victoria.
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Information regarding consent, confidentiality, access to
data and dissemination policy have been disclosed in the
PICF.
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